Loading organizations...
Loading organizations...
Biopharmaceutical company focused on influenza prevention and treatment.
FluGen has raised $12.0M across 1 funding round.
FluGen has raised $12.0M in total across 1 funding round.
FluGen has raised $12.0M in total across 1 funding round.
FluGen's investors include Paul Weiss, Knox, State of Wisconsin Investment Board, WARF Ventures.
FluGen has raised $12.0M across 1 funding round. Most recently, it raised $12.0M Series A in August 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 25, 2015 | $12.0M Series A | Paul Weiss | Knox, State of Wisconsin Investment Board, WARF Ventures |